Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guerin treatment

Article (Web of Science), Early Access (Web of Science)

• cited authors: Alanee, Shaheen; Sana, Sherjeel; El-Zawahry, Ahmed; Peabody, James; Pearce, Tiffany; Adams, Nicole; Deebajah, Mustafa; Crabtree, Jane; Delfino, Kristin; McVary, Kevin; Robinson, Kathy; Rao, Krishna
• publication date: May 8, 2021
• webpage: Web of Science
• published in: WORLD JOURNAL OF UROLOGY Journal
• category: UROLOGY & NEPHROLOGY Category

keywords

• Bacillus Calmette–
• Bladder cancer
• Cystectomy
• Gué
• Non-muscle invasive
• Pembrolizumab
• rin